BioSpace News Archive

IACTA Pharmaceuticals, Inc. (“IACTA”), an innovation leader in ophthalmic therapeutics, today announced the expansion of its Scientific Advisory Board (SAB) with the appointments of Dr. Richard L. Abbott and Dr. Lixin Xie.

Esteemed cancer researcher and co-founder of GV20 Shirley Liu appointed as Chief Executive Officer.

Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced the initiation of its Phase 3 study evaluating LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery.

GeneIQ, a molecular diagnostics (MDx) company based in Dallas, Texas , announces the debut of their One Choice® Report and Antimicrobial Stewardship Program.

Now made ultra-portable with Clarius, ImaCor’s Zura Handheld Hemodynamic Ultrasound ™ has received FDA clearance as the world’s first handheld transesophageal echocardiography (TEE) system, enabling more clinicians to accurately determine appropriate interventions in real-time.

CollPlant today announced the initiation of a study in large animals for its 3D bioprinted regenerative breast implant program, addressing the $2.8 billion global breast implant market.

Global Radiology Market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029.

FMLS is a CAP accredited laboratory, meaning that it has undergone stringent regulatory inspections to verify that the laboratory meets all required standards from CLIA and OSHA.

Orphazyme A/S, held its Annual General Meeting, at which the Annual General Meeting.

The global postpartum depression market size reached USD 5.10 Billion in 2021 and is expected to register a revenue CAGR of 30.4% during the forecast period, according to latest analysis by Emergen Research.